Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial
- DOI
- 10.1002/cncr.35840
- Published
- 2025-04-07
- Container
- Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cncr.35840,
title = {Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial},
author = {Hannah Goulart and Hagop Kantarjian and Gautam Borthakur and Naval Daver and Courtney D. DiNardo and Elias Jabbour and Naveen Pemmaraju and Yesid Alvarado and Himachandana Atluri and Musa Yilmaz and Fadi G. Haddad and Kayleigh R. Marx and Caitlin Rausch and Sanam Loghavi and Nitin Jain and Guillermo Garcia‐Manero and Farhad Ravandi‐Kashani and Tapan M. Kadia},
year = {2025},
journal = {Cancer},
doi = {10.1002/cncr.35840},
url = {https://doi.org/10.1002/cncr.35840}
}RIS
TY - JOUR TI - Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial AU - Hannah Goulart AU - Hagop Kantarjian AU - Gautam Borthakur AU - Naval Daver AU - Courtney D. DiNardo AU - Elias Jabbour AU - Naveen Pemmaraju AU - Yesid Alvarado AU - Himachandana Atluri AU - Musa Yilmaz AU - Fadi G. Haddad AU - Kayleigh R. Marx AU - Caitlin Rausch AU - Sanam Loghavi AU - Nitin Jain AU - Guillermo Garcia‐Manero AU - Farhad Ravandi‐Kashani AU - Tapan M. Kadia PY - 2025 JO - Cancer DO - 10.1002/cncr.35840 UR - https://doi.org/10.1002/cncr.35840 ER -
APA
Goulart, H., Kantarjian, H., Borthakur, G., Daver, N., DiNardo, C. D., Jabbour, E., Pemmaraju, N., Alvarado, Y., Atluri, H., Yilmaz, M., Haddad, F. G., Marx, K. R., Rausch, C., Loghavi, S., Jain, N., Garcia‐Manero, G., Ravandi‐Kashani, F., & Kadia, T. M. (2025). Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial. Cancer. https://doi.org/10.1002/cncr.35840
Source records
- crossref · retrieved 2026-09-26T22:01:44.152Z